Intestinal epithelial cell surface glycans and gangliosides

Intestinal epithelial cell surface glycans and gangliosides are complex carbohydrate-containing molecules, including glycoproteins and glycosphingolipids, that form the functional interface of the gut mucosa. These molecules play essential roles in cell-cell recognition, signal transduction, and the maintenance of the intestinal barrier's structural integrity [1, 2]. They are critically involved in human disease as the primary attachment sites for numerous enteric pathogens and toxins [3]. For example, the GM1 ganglioside serves as the specific receptor for the cholera toxin produced by Vibrio cholerae [3, 4]. Pharmacological targeting of these structures typically involves the use of glycan mimetics or probiotics to competitively inhibit pathogen adhesion or neutralize toxins [5]. Furthermore, alterations in the glycosylation patterns of the intestinal epithelium are associated with chronic inflammatory conditions and the progression of colorectal malignancies [2, 6]. Therapeutic strategies also explore the use of these glycans as decoys to divert pathogens away from the cell surface [5]. Understanding the specific glycan-protein interactions is vital for developing targeted anti-infective therapies that do not disrupt the host's normal physiological processes [1].

Other names

Enterocyte surface glycoconjugatesIntestinal glycosphingolipidsGut mucosal glycansIntestinal cell surface carbohydrates

Competitive inhibition of pathogen and toxin binding to host cell surface receptors; modulation of mucosal immune response; stabilization of the intestinal epithelial barrier.